Related Experiment Video
Updated: Aug 6, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Endothelial Histone Deacetylase 1 Activity Impairs Kidney Microvascular NO Signaling in Rats fed a High Salt Diet
Luke S Dunaway1, Anthony K Cook1, Davide Botta2
1Section of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL USA.
A high salt diet impairs kidney NO signaling via histone deacetylase 1 (HDAC1) activation. This endothelial dysfunction is mediated by a plasma factor, suggesting new therapeutic targets for salt-induced kidney issues.
Area of Science:
- Renal physiology and cardiovascular research
- Endothelial cell biology
- Molecular mechanisms of diet-induced disease
Background:
- High salt (HS) intake is linked to endothelial dysfunction and reduced nitric oxide (NO) production in kidney microvasculature.
- The precise molecular pathways by which HS impairs NO signaling remain incompletely understood.
Approach:
- Investigated the role of histone deacetylase 1 (HDAC1) in HS-induced NO signaling impairment in rat kidney microvascular endothelial cells.
- Utilized a blood-perfused juxtamedullary nephron preparation and isolated kidney endothelial cells to assess NO signaling and HDAC1 activity.
- Identified a plasma-derived factor mediating endothelial dysfunction.
Key Points:
- HS diet impaired NO signaling in the afferent arteriole, which was reversed by HDAC1 inhibition.
- Increased HDAC1 activity was observed in kidney endothelial cells from HS-fed rats.
- A humoral factor, termed Plasma Derived Endothelial-dysfunction Mediator (PDEM), was identified as responsible for HS-induced endothelial dysfunction.
Conclusions:
- HS diet activates endothelial HDAC1 through PDEM, leading to decreased NO signaling in renal microvasculature.
- This study elucidates novel molecular mechanisms underlying HS-induced endothelial dysfunction.
- Findings suggest potential therapeutic strategies targeting HDAC1 or PDEM for managing salt-sensitive hypertension.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin II Receptor Blockers

